egl-4 Acts Through a Transforming Growth Factor-ß/SMAD Pathway in Caenorhabditis elegans to Regulate Multiple Neuronal Circuits in Response to Sensory Cues

Corresponding author: Piali Sengupta, Department of Biology and Volen Center for Complex Systems, Brandeis University, 415 South St., Waltham, MA 02454., sengupta{at}brandeis.edu (E-mail)

Communicating editor: R. K. HERMAN

	ABSTRACT

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION LITERATURE CITED

Sensory cues regulate several aspects of behavior and development in Caenorhabditis elegans, including entry into and exit from an alternative developmental stage called the dauer larva. Three parallel pathways, including a TGF-ß-like pathway, regulate dauer formation. The mechanisms by which the activities of these pathways are regulated by sensory signals are largely unknown. The gene egl-4 was initially identified based on its egg-laying defects. We show here that egl-4 has many pleiotropies, including defects in chemosensory behavior, body size, synaptic transmission, and dauer formation. Our results are consistent with a role for egl-4 in relaying sensory cues to multiple behavioral and developmental circuits in C. elegans. By epistasis analysis, we also place egl-4 in the TGF-ß-like branch and show that a SMAD gene functions downstream of egl-4 in multiple egl-4-regulated pathways, including chemosensation.

ORGANISMS make complex behavioral and developmental decisions on the basis of sensory cues in their environment. The nematode Caenorhabditis elegans responds to multiple types of sensory signals, including chemical, mechanical, and thermal stimuli (for recent reviews, see DRISCOLL and KAPLAN 1997 ; TROEMEL 1999 ). Responses to these stimuli are mediated by well-defined circuits consisting of ciliated sensory neurons, interneurons, and motor neurons (WHITE et al. 1986 ). Functions of individual sensory neurons have been defined by laser killing experiments, and it has been shown that distinct subsets of sensory neurons are required for the response to each type of stimulus (CHALFIE et al. 1985 ; BARGMANN and HORVITZ 1991A ; BARGMANN et al. 1993 ; KAPLAN and HORVITZ 1993 ; MORI and OHSHIMA 1995 ).

Several aspects of C. elegans behavior and development are regulated by environmental signals. Chemical cues direct movement toward sources of food and away from toxic compounds. Behaviors such as locomotion, pharyngeal pumping, defecation, foraging, and egg laying are also modulated by sensory cues (HORVITZ et al. 1982 ; AVERY and HORVITZ 1990 ; THOMAS 1990 ; LIU and THOMAS 1994 ). In addition, environmental stimuli regulate developmental decisions such as entry into and exit from an alternative third larval stage called the dauer larva (for review, see RIDDLE and ALBERT 1997 ). Dauer larvae are specialized for survival and dispersal in harsh environmental conditions and can recover and resume reproductive growth when conditions improve.

The decision to enter into or recover from the dauer stage is made through the assessment of multiple parallel sensory and developmental inputs. A high concentration of a constitutively produced pheromone signals increased population density and is the primary chemosensory signal regulating dauer formation (GOLDEN and RIDDLE 1982 , GOLDEN and RIDDLE 1984B , GOLDEN and RIDDLE 1985 ). In addition, high temperature and low levels of food indicate adverse conditions and also promote dauer formation (GOLDEN and RIDDLE 1984A , GOLDEN and RIDDLE 1984B ). Thus, regulation of dauer entry and exit requires integration of information from multiple sensory pathways and provides an excellent model system in which to investigate several aspects of neuronal function.

Three signaling pathways that act in parallel to regulate dauer formation have been defined (Fig 1; VOWELS and THOMAS 1992 ; THOMAS et al. 1993 ; GOTTLIEB and RUVKUN 1994 ; RIDDLE and ALBERT 1997 ). Most major players in each of these pathways have been identified by studying mutants that either enter the dauer state inappropriately under noninducing conditions [dauer-formation constitutive (Daf-c)], or fail to enter the dauer state under inducing conditions [dauer-formation defective (Daf-d)]. The group I Daf-c genes are thought to act by activating the ASJ chemosensory neurons among others to promote dauer formation under inducing conditions (VOWELS and THOMAS 1992 ; THOMAS et al. 1993 ; SCHACKWITZ et al. 1996 ). The group II Daf-c genes constitute a transforming growth factor-ß (TGF-ß)-like signaling pathway and function to repress dauer formation under noninducing conditions via the ASI, ADF, and ASG neurons (BARGMANN and HORVITZ 1991B ; SCHACKWITZ et al. 1996 ; RIDDLE and ALBERT 1997 ; PATTERSON and PADGETT 2000 ). Under noninducing conditions, the DAF-7 TGF-ß homolog is produced by the ASI neurons (REN et al. 1996 ; SCHACKWITZ et al. 1996 ). The DAF-7 signal is transduced via the DAF-4 TGF-ß type II and the DAF-1 TGF-ß type I receptors, as well as the DAF-8 and DAF-14 SMAD proteins (GEORGI et al. 1990 ; ESTEVEZ et al. 1993 ; RIDDLE and ALBERT 1997 ; INOUE and THOMAS 2000 ). This pathway antagonizes the action of the DAF-3 SMAD protein and the daf-5 gene product (as yet uncloned) to repress dauer development (PATTERSON et al. 1997 ). In a third pathway, an insulin-like ligand(s) represses dauer formation via the DAF-2 insulin receptor and the AGE-1 phosphatidylinositol-3-OH kinase (MORRIS et al. 1996 ; KIMURA et al. 1997 ). This pathway is antagonized by the DAF-18 PTEN phosphatase and the DAF-16 forkhead domain protein (LARSEN et al. 1995 ; LIN et al. 1997 ; OGG et al. 1997 ; OGG and RUVKUN 1998 ; GIL et al. 1999 ; ROUAULT et al. 1999 ). It is equally likely that these pathways act to promote reproductive growth as opposed to repressing dauer arrest. As shown in Fig 1, these pathways are thought to converge at the DAF-12 nuclear hormone receptor (RIDDLE and ALBERT 1997 ; ANTEBI et al. 1998 ). The signals from these parallel pathways are integrated via unknown mechanisms and transduced to result in coordinated developmental changes in multiple tissue types throughout the animal.

View larger version (21K): In this window In a new window Download PPT slide   Figure 1. Parallel pathways mediate dauer formation. Genes described in this work are included in each pathway. GC, guanylyl cyclase; Hsp90, heat shock protein 90; TGF-ßR, TGF-ß receptor; NHR, nuclear hormone receptor; insulin R, insulin receptor; PI3 kinase, phosphoinositide-3-OH kinase. See text for additional details.

To reflect environmental changes accurately, it is crucial that the activities of the three major dauer regulatory pathways are appropriately regulated in response to sensory and developmental signals. The sensory cues pheromone, temperature, and food have been shown to regulate expression of the DAF-7 TGF-ß ligand (REN et al. 1996 ; SCHACKWITZ et al. 1996 ). Although the principal sensory neurons and genes regulating dauer formation have been identified, it is unclear how multiple sensory and developmental inputs are translated into modulation of each of these pathways. Since each branch of the dauer pathway is regulated by parallel sensory inputs, there is likely to be functional redundancy among genes that play roles in such regulatory events. One might also expect that these genes would function in several aspects of neuronal function and thus would show pleiotropic mutant phenotypes.

The genes unc-31, unc-64, and unc-3 were initially identified on the basis of the impaired movement of mutants (BRENNER 1974 ). unc-31 and unc-64 mutants show pleiotropic phenotypes consistent with their general effects on neuronal function. unc-31 and unc-64 encode a CAPS-related protein and a syntaxin homolog, respectively; these proteins are required for calcium-regulated secretion (LIVINGSTONE 1991 ; AVERY et al. 1993 ; NGUYEN et al. 1995 ; ANN et al. 1997 ; OGAWA et al. 1998 ; SAIFEE et al. 1998 ). Mutations in these genes also affect the dauer pathway. While animals singly mutant in one of these genes form very few dauers under noninducing conditions, double mutant combinations with other genes result in a strong synthetic Daf-c phenotype (Syn-Daf; AILION et al. 1999 ). The Daf-c phenotype of unc-31 and unc-64 mutants is strongly suppressed by mutations in daf-16, suggesting that these genes may regulate insulin release in response to sensory and/or metabolic signals (AILION et al. 1999 ). Similarly, unc-3 mutants also show a number of pleiotropies, including a Syn-Daf phenotype (I. KATSURA, personal communication; this work). unc-3 encodes an Olf-1/EBF1-like transcription factor that regulates expression of genes such as daf-7, as well as cholinergic genes in motor neurons (M. AILION and J. H. THOMAS, unpublished results; P. REN and D. RIDDLE, personal communication; T. STARICH and J. SHAW, personal communication; K. LICKTEIG and D. MILLER, personal communication; PRASAD et al. 1998 ). unc-3 functions in the TGF-ß-mediated pathway for dauer formation, and the Daf-c phenotype of unc-3 mutants is fully suppressed by daf-3 and daf-5 mutations (M. AILION and J. H. THOMAS, unpublished results).

Studying genes with weak Daf-c phenotypes can therefore provide information about the mechanisms involved in the modulation of dauer regulatory signals, in addition to providing insight into specific aspects of neuronal function. Here we describe characterization of the gene egl-4. egl-4 was initially identified in screens for mutants defective in egg-laying behavior (TRENT et al. 1983 ). We show that mutations in egl-4 result in several pleiotropies that include chemosensory defects, altered body length, and defects in synaptic transmission. We also find that egl-4 plays a role in relaying sensory cues to the egg-laying circuit. Moreover, we show that similar to unc-31, unc-64, and unc-3 mutants, egl-4 mutants are Syn-Daf and exhibit defects in dauer formation. Finally, we show that egl-4 mutations deregulate the TGF-ß branch of the dauer pathway, and that most defects of egl-4 mutants, including chemosensory defects, are variably suppressed by mutations in daf-3 and daf-5. To our knowledge, this is the first report that implicates a SMAD protein in chemosensory signaling.

	MATERIALS AND METHODS

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION LITERATURE CITED

Strains:
Wild-type worms used were C. elegans variety Bristol, strain N2. Worms were grown using standard methods (BRENNER 1974 ).

Strains carrying the following mutations were used in this work. Strains were obtained from the Caenorhabditis Genetics Center unless noted otherwise. Mutations are listed by linkage group:

• LGI: daf-16(m27), daf-16(mgDf50), dpy-5(e61), egl-32(n155), unc-13(e450), unc-29(e1072), unc-75(e950).

• LGII: daf-5(e1385), dpy-10(e128), kyIs37[odr-10-GFP::lin-15], tph-1(mg280), tra-2(q276), unc-4(e120), unc-52(e444).

• LGIII: daf-2(e1370), daf-7(e1372), tax-4(ks11), unc-64(e246).

• LGIV: daf-14(m77), egl-4(n477), egl-4(n479), egl-4(n612), egl-4(n579), egl-4(n478), flp-1(yn2), osm-3(p802), unc-31(e928).

• LGV: daf-11(sa195), osm-6(p811).

• LGX: daf-3(e1376), daf-12(m20), dpy-3(e127), kyIs53[odr-10-GFP(tagged)::lin-15], unc-1(e719), unc-3(e151), unc-6(e78), unc-58(e665).

flp-1(yn2) was obtained from C. Li; tph-1(mg280) was obtained from J. Y. Sze and G. Ruvkun; kyIs37 and kyIs53 were generated in the laboratory of C. I. Bargmann. The strain carrying mEx47[daf-7-GFP::rol-6] was obtained from D. Riddle. unc-64(e246) was outcrossed once to remove an unlinked temperature-sensitive sterile mutation; the egl-4 alleles n477, n479, and n612 were outcrossed an additional two times before analysis. The following strains carrying multiple mutations were obtained from the Caenorhabditis Genetics Center: lin-1(e1275) unc-33(e204) IV, dpy-9(e12) ced-2(e1752) lin-1(e1275) IV. The following two strains were obtained from H. R. Horvitz: egl-32(n155) I; daf-3(e1376) X and egl-32(n155) I; daf-5(e1385) II.

Behavioral screens and assays:
odr-9(ky27) and odr-9(ky185) were isolated in behavioral screens for mutants unable to chemotax towards diacetyl, essentially as described previously (BARGMANN et al. 1993 ; SENGUPTA et al. 1994 , SENGUPTA et al. 1996 ). Mutants were outcrossed a total of four times prior to further characterization. Population assays toward volatile and water-soluble chemicals were performed as described previously (BARGMANN and HORVITZ 1991A ; BARGMANN et al. 1993 ).

Noncomplementation between odr-9 and egl-4:
odr-9(ky27) and odr-9(ky185) failed to complement for the defect in response toward diacetyl. odr-9(ky27) was mapped to the left arm of LGIV using standard mapping crosses. odr-9(ky27)/egl-4(n478) and odr-9(ky185)/egl-4(n478) trans-heterozygotes failed to complement for the phenotypes of chemotaxis defects, egg-laying defects, altered body size, darkened intestines, and hyperforaging behavior. All alleles of egl-4 were recessive for all phenotypes tested.

Egg-laying assays:
To count and stage eggs, N2 and egl-4 adult hermaphrodites were mounted on agarose pads and viewed under Nomarski optics at x400 magnification. Animals were grown at 20°, and first day adults were analyzed. To determine if egl-4 is responsive to food cues, single N2, egl-4(n478), and flp-1(yn2) adult hermaphrodites were placed on standard worm growth plates with either no food or a day-old lawn of bacteria. Animals were allowed to lay eggs for 2–3 hr at room temperature. Animals were then picked off the plate and the number of eggs laid was counted.

Dauer assays:
Age-synchronized animals were allowed to lay eggs at room temperature for 3–6 hr. Parent animals were then removed and plates were incubated at the given assay temperatures. Dauer and nondauer animals were counted after 100 hr at 15°, 65 hr at 20°, 48 hr at 25°, and 44 hr at 27°. This permitted the scoring of transient dauers that recover rapidly. Small differences in temperature >25° can make significant differences in the number of dauers formed, so each set of assays included all the relevant strains. All relevant comparisons are between strains assayed in parallel. Plates with partially purified dauer pheromone were prepared as described (VOWELS and THOMAS 1994 ). Additional details on the protocol followed for dauer assays are provided elsewhere (AILION and THOMAS 2000 ).

Serotonin assays:
Serotonin was made as a 10 mg/ml stock solution in water and added to a final concentration of 1, 2, or 5 mg/ml to worm growth agar immediately before pouring. Plates were seeded with concentrated bacteria immediately before use. Dauer formation was assayed after 43 hr following synchronous egglays. After counting, plates were returned to 27° and incubated for an additional 4 days, after which the number of nondauers was counted to score for dauer recovery.

Aldicarb and levamisole assays:
The effects of aldicarb and levamisole were scored in acute paralysis assays as follows. For both assays, plates were seeded with bacteria the day before the assay. A total of 20 young adult animals were picked to each of two duplicate plates. Aldicarb was made as a 100 mM stock solution in 70% ethanol and added to a final concentration of 0.5 or 1.0 mM to worm growth agar immediately before pouring. Animals were scored for movement and pharyngeal pumping when prodded with a platinum wire after 6, 8, and 10 hr. To most clearly show the differences between resistant and nonresistant strains, we plotted the percentage paralysis on 0.5 mM aldicarb at 10 hr, where paralyzed is defined as failure to move when prodded. Strains defined as resistant were clearly different from wild type at all time points and concentrations. Levamisole was made as a 100 mM stock solution in water and added to agar to a final concentration of 100 µM. Acute paralysis was scored every 30 min for 2 hr. Paralysis was defined as the absence of any moving or pumping when animals were prodded with a platinum wire.

Construction of double and triple mutant strains:
Double mutants between egl-4 and various daf-c or daf-d mutations were constructed and confirmed by the methods described previously (VOWELS and THOMAS 1992 ; THOMAS et al. 1993 ). Briefly, egl-4 double mutants with daf-c mutations were built by first constructing egl-4/+; daf-c/+ heterozygotes. egl-4 was homozygosed by picking Egl animals. Subsequently, the daf-c mutation was homozygosed by picking dauers and recovering them. egl-4 double mutants with daf-d mutations were built by constructing egl-4/+; daf-d/m heterozygotes where m is a visible marker. egl-4 was homozygosed by picking Egl animals, and the daf-d mutation was homozygosed by picking animals that failed to segregate the marker m. Markers used were as follows: daf-16—dpy-5(e61) unc-75(e950) or unc-13(e450); daf-3—unc-1(e719) dpy-3(e27); daf-5—unc-52(e444); daf-12—unc-58(e665) or unc-6(e78). The unexpected strong suppression of the 27° Daf-c phenotype of egl-4(n479) in several double mutants made us examine whether the 27° Daf-c mutation was actually present in the double mutants and hence whether the 27° Daf-c mutation was identical to the egl-4 mutation. First, we confirmed that the 27° Daf-c mutation in n479 mutants mapped to the same region as egl-4. Second, we deconstructed the egl-4(n479); daf-3 and daf-16; egl-4(n479) strains to reisolate the egl-4 mutation. In both cases, all egl-4 homozygotes generated were strongly Daf-c at 27°, indicating that the suppressed strains do contain the daf-c mutation and that it is tightly linked to egl-4.

An egl-4 osm-3 double mutant was constructed by first generating osm-3/egl-4 unc-33 heterozygotes. Egl non-Unc Osm recombinant progeny were selected and homozygosed. The egl-4; osm-6 double mutant was built by successively homozygosing egl-4 and osm-6 by the Egl and Osm or Dyf phenotypes, respectively. tph-1 doubles were built by picking Egl (egl-4) or Unc (unc-31, unc-64, or unc-3) animals segregating from tph-1/m; egl-4 or unc/+ heterozygotes, where m was dpy-10(e128) unc-4(e120), except in the case of the unc-3 double, where m was tra-2(q276). Animals that failed to segregate m were presumed to carry tph-1, which was also scored by a low-penetrance withered tail (Wit) phenotype. Triple mutants of egl-4; unc-3 with daf-5 or daf-16 were built by picking dauers from egl-4/+; unc-3/+; daf-5/unc-52 or daf-16/+ heterozygotes to homozygose both egl-4 and unc-3 simultaneously. After dauers recovered, daf-5 was homozygosed by picking animals that failed to segregate Unc animals, while daf-16 was homozygosed by picking partial dauers. The egl-32; egl-4 double mutant was constructed by crossing unc-13/+; egl-4/+ males with egl-32 hermaphrodites. Non-Egl cross-progeny were picked individually, and those segregating Unc animals were kept. Egl animals from these plates were again picked singly, and those segregating Unc animals were selected as animals having the genotype egl-32/unc-13; egl-4/egl-4. egl-32 was homozygosed by picking animals that failed to segregate Unc progeny. Presence of the appropriate single mutations was confirmed by complementation testing for visible or behavioral phenotypes. Additional details on strain constructions are available upon request.

The rationale behind the selection of alleles for some double mutant constructions is as follows. The tph-1(mg280), unc-3(e151), unc-31(e928), daf-11(sa195), daf-14(m77), and daf-16(mgDf50) alleles are likely null alleles (AVERY et al. 1993 ; OGG et al. 1997 ; PRASAD et al. 1998 ; BIRNBY et al. 2000 ; INOUE and THOMAS 2000 ; SZE et al. 2000 ). daf-7(e1372) mutants have been shown previously to exhibit a Daf-c phenotype equivalent in strength to that of animals carrying a predicted daf-7 null allele (REN et al. 1996 ). daf-2(e1370) results in severe loss of daf-2 function; no clear daf-2 null mutations have been identified (KIMURA et al. 1997 ). It has been shown previously that the Daf-c phenotype of daf-7(e1372) and daf-2(e1370) mutants is strongly enhanced in double mutant combinations with mutations in parallel branches of the dauer pathway, but not with mutations in the same branch (THOMAS et al. 1993 ). daf-3(e1376) and daf-16(m27) alleles have been shown to suppress Daf-c phenotypes to a similar degree as the respective null alleles, and therefore likely represent strong loss-of-function mutations (THOMAS et al. 1993 ; GOTTLIEB and RUVKUN 1994 ; OGG et al. 1997 ; PATTERSON et al. 1997 ).

Statistical analysis:
In all analyses involving comparisons among multiple groups, statistical significance was determined using the Bonferroni-Dunn multiple comparisons procedure, with the significance level set at 5%. Analyses were performed using the Statview 4.5 application (Abacus Concepts, Berkeley, CA).

	RESULTS

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION LITERATURE CITED

odr-9 and egl-4 are allelic:
We identified two alleles of the gene odr-9 (ky27 and ky185) in behavioral screens for mutants unable to respond to the volatile attractive chemical diacetyl (see MATERIALS AND METHODS). We placed odr-9 in the same genetic interval as the previously identified gene egl-4 using standard three-factor mapping crosses (data not shown). Five alleles of egl-4 (n477, n478, n479, n579, and n612) have been identified in genetic screens for mutants with defects in egg-laying behavior (TRENT et al. 1983 ). We found that odr-9 and egl-4 are allelic. n478/ky27 and n478/ky185 trans-heterozygotes fail to complement for all phenotypes tested (see MATERIALS AND METHODS). This gene is henceforth referred to as egl-4. Here we present detailed characterization of seven alleles of egl-4.

egl-4 mutants are egg-laying defective:
Since several alleles of egl-4 had been previously identified on the basis of their egg-laying defects, we further examined the egg-laying behavior of all egl-4 mutants. Egg-laying behavior has been described as biphasic, with periods of active egg laying interspersed with inactive periods (WAGGONER et al. 1998 ). Induction of entry into the active phase is regulated by sensory cues and is mediated by the neurotransmitters serotonin and FMRFamide-related neuropeptides (HORVITZ et al. 1982 ; TRENT et al. 1983 ; WEINSHENKER et al. 1995 ; WAGGONER et al. 2000 ). Within the active phase, the rate of egg laying is regulated by an additional neurotransmitter, acetylcholine (ACh; TRENT et al. 1983 ; WEINSHENKER et al. 1995 ; WAGGONER et al. 1998 ). It has been reported previously that egl-4 mutants exhibit normal rates of egg laying within the active phase, but have longer latent periods between active phases (WAGGONER et al. 1998 ). Consistent with this, egl-4 mutants experience "transient bloating," where animals become filled with eggs but eventually lay most of their eggs. In Table 1 we examined this egg-laying phenotype in two ways. First, we counted the number of eggs retained in the uterus of adult hermaphrodites and found that egl-4 mutants retain approximately three times as many eggs as wild-type adults of comparable stage. We also examined the developmental stages of eggs retained in the uterus of egl-4 mutants. Typically, early events in embryogenesis occur in utero; eggs are laid during gastrulation (at 120–180 min postfertilization). We find that 30% of the eggs retained in egl-4 mutants are at the comma stage or later in development (400 min postfertilization or later). Eggs at this late developmental stage are rarely if ever observed in the uterus of well-fed wild-type hermaphrodites. Thus, egl-4 mutants lay eggs at a later developmental stage, likely as a consequence of delayed active egg-laying periods. All alleles appear to cause significant defects with no clear allelic series.

Since entry into the active phase of egg laying is regulated partly by serotonin, the defects of egl-4 mutants could result from pre- or postsynaptic defects in the serotonergic pathway. The egg-laying phenotype of egl-4 mutants is variably responsive to both serotonin and imipramine (a serotonin reuptake inhibitor; S. A. DANIELS and P. SENGUPTA, data not shown; TRENT et al. 1983 ), suggesting that egl-4 could function both pre- and postsynaptically. egl-4 could also act to potentiate the effect of serotonin on initiating the active phase of egg laying (WAGGONER et al. 2000 ). Such a function has been ascribed to the FMRFamide-related neuropeptides encoded by the flp-1 gene. flp-1 plays a role in relaying sensory cues to the egg-laying circuit such that the rate of egg laying in flp-1 mutants is insensitive to food signals (WAGGONER et al. 2000 ). To determine if egl-4 functions similarly, we compared the rate of egg laying in n478 mutants in the presence or absence of a bacterial food source. We find that egg laying by egl-4 mutants is insensitive to regulation by food cues (Fig 2). While egg laying by wild-type animals is significantly suppressed in the absence of food, the rate of egg laying in egl-4 mutants is unaffected. Thus, egl-4 may function to relay sensory cues to modulate the egg-laying circuit.

View larger version (22K): In this window In a new window Download PPT slide   Figure 2. Egg laying by egl-4 mutants is insensitive to food cues. Mean number of eggs laid per hour with or without food present is shown. The numbers of independent animals tested for each condition are indicated under the appropriate bars. Egg laying in wild-type animals is decreased in the absence of food (P < 0.001). Egg laying in egl-4 and flp-1 mutants is not significantly altered in the absence of food (P 0.05). P values were determined using the Mann-Whitney rank sum test.

egl-4 mutants exhibit multiple defects in chemosensory behaviors:
The ky27 and ky185 alleles were isolated on the basis of their failure to respond to the volatile odorant diacetyl. We examined the chemosensory behaviors of all egl-4 alleles, and show that egl-4 mutants have widespread chemosensory defects.

Attractive volatile chemicals: Attractive volatile chemicals are sensed by the bilaterally symmetrical ciliated neuron types AWA and AWC (BARGMANN et al. 1993 ). AWA neurons mediate responses to the chemicals diacetyl (2,3-butanedione) and pyrazine, while AWC neurons are required for the attractive response to the volatile chemicals benzaldehyde, isoamyl alcohol, butanone, and 2,3-pentanedione. Both neuron types are required for the response to the chemical trimethylthiazole. Signaling molecules such as olfactory receptors, G proteins, and ion channels that function in each of these neuron types have been identified previously (COBURN and BARGMANN 1996 ; KOMATSU et al. 1996 ; SENGUPTA et al. 1996 ; COLBERT et al. 1997 ; ZWAAL et al. 1997 ; ROAYAIE et al. 1998 ; JANSEN et al. 1999 ; TROEMEL et al. 1999 ).

We first examined the responses of all egl-4 mutants to odorants sensed by the AWA neurons. As shown in Fig 3, all egl-4 alleles tested exhibit very strong defects in the response to diacetyl and weaker but significant defects in the response to pyrazine. Since egl-4 mutants retain residual responses to pyrazine, egl-4 alleles likely affect a subset of functions rather than overall development of the AWA neurons. Diacetyl is recognized by the seven-transmembrane domain olfactory receptor ODR-10, which is expressed specifically in the AWA neurons and is localized to their sensory cilia (SENGUPTA et al. 1996 ). To determine if the strong diacetyl defect of egl-4 results from defects in odr-10 expression or localization, we examined expression and subcellular localization of a green fluorescent protein (GFP)-tagged ODR-10 fusion protein in n478 animals. Both expression and localization of ODR-10 were unaltered in n478 mutants (data not shown). We have shown previously that while odr-10 null mutants fail to respond to 1 nl of diacetyl, they respond relatively normally to 100 nl of diacetyl (SENGUPTA et al. 1996 ). Diacetyl (1 nl) is sensed exclusively by the AWA neurons, while higher concentrations are sensed redundantly by the AWA and AWC neurons (P. SENGUPTA and C. I. BARGMANN, unpublished results). However, egl-4 mutants fail to respond to all concentrations of diacetyl tested (Fig 3D), consistent with defects in both the AWA and AWC chemosensory neurons.

View larger version (26K): In this window In a new window Download PPT slide   Figure 3. Responses of egl-4 mutants to odorants sensed by the AWA neurons. Responses of egl-4 mutants to a point source of (A) 1 nl of diacetyl; (B) 1 µl of 10 mg/ml pyrazine; (C) 1 µl of 1:1000 dilution of trimethylthiazole; and (D) 100, 10, and 1 nl of diacetyl. Each data point represents the mean of at least six independent assays using 200 animals in each assay. Error bars equal the SEM. Single asterisks mark responses that are different from wild type at P 0.01; double asterisks mark responses that are different at P 0.001. C.I., chemotaxis index.

We next tested the responses of egl-4 mutants to additional odorants sensed by the AWC neurons. While all alleles have normal responses to the odorant benzaldehyde, they have weaker defects in the responses to butanone and isoamyl alcohol, and strong defects in the response to 2,3-pentanedione, an odorant structurally related to diacetyl (Fig 4). Overall, n478 has the strongest defects and n477 has the weakest defects. All egl-4 mutants except n478 exhibit wild-type response to trimethylthiazole (Fig 3C).

View larger version (31K): In this window In a new window Download PPT slide   Figure 4. Responses of egl-4 mutants to odorants sensed by the AWC neurons. Responses of egl-4 mutants to a point source of (A) 1 µl of 1:200 benzaldehyde, (B) 1 µl of 1:1000 dilution of butanone, (C) 1 µl of 1:100 dilution of isoamyl alcohol, and (D) 1 µl of 1:1000 dilution of 2,3-pentanedione. Each data point represents the mean of at least six independent assays using 200 animals in each assay. Error bars equal the SEM. Single asterisks mark responses that are different from wild type at P 0.01; double asterisks mark responses that are different at P 0.001.

Attractive water-soluble chemicals: C. elegans is also attracted to water-soluble chemicals such as NaCl and lysine (WARD 1973 ; DUSENBERY 1974 ; BARGMANN and HORVITZ 1991A ). This behavior is mediated largely by the ASE ciliated neuron type, with minor contributions from additional neurons (ASG, ASI, ADF, and ASK; BARGMANN and HORVITZ 1991A ). In addition to widespread defects in responses to volatile attractive chemicals, we found that all egl-4 mutants have strong defects in their responses to NaCl and lysine (Fig 5). The morphology of a subset of ciliated neurons (ASI, ASK, ADL, AWB, ASH, and ASJ) can be visualized by filling animals with the lipophilic dye DiO (PERKINS et al. 1986 ; HERMAN and HEDGECOCK 1990 ). Neurons of mutants with defects in the structure of the sensory cilia often fail to fill with dye (PERKINS et al. 1986 ; STARICH et al. 1995 ). However, egl-4 mutants dye-fill normally, and no obvious defects in the morphology of the neurons were visible (data not shown).

View larger version (24K): In this window In a new window Download PPT slide   Figure 5. Responses of egl-4 mutants to water-soluble chemicals. Shown are responses of egl-4 mutants to 0.2 M NaCl and to 0.5 M lysine. Each data point represents the mean of five independent assays using 100 animals in each assay. Error bars equal the SEM. All responses differ from wild type at P < 0.001.

We also examined additional sensory behaviors. These included repulsion from volatile repellents, responses to mechanical cues such as nose touch and osmotic shock, and responses to gentle body touch. Sensory neurons mediating each of these behaviors have been identified (CHALFIE et al. 1985 ; BARGMANN et al. 1990 ; KAPLAN and HORVITZ 1993 ; TROEMEL et al. 1995 , TROEMEL et al. 1997 ). egl-4 mutants were found to be wild type in their responses to these stimuli (data not shown), indicating that mutations in egl-4 affect the functions of a restricted subset of neurons.

egl-4 mutants are hypersensitive to dauer-inducing conditions:
Dauer formation is dependent on the perception of chemosensory cues such as dauer pheromone and food. These cues are sensed by ciliated neurons (BARGMANN and HORVITZ 1991B ; SCHACKWITZ et al. 1996 ). Mutants with chemosensory defects often have defects in the regulation of dauer formation (LEWIS and HODGKIN 1977 ; ALBERT et al. 1981 ; RIDDLE et al. 1981 ; THOMAS 1993 ; VOWELS and THOMAS 1994 ; COBURN et al. 1998 ). In addition to the chemosensory defects described above, egl-4 mutants also show defects in the dauer formation process. egl-4(n478) has been shown previously to be hypersensitive to dauer pheromone (GOLDEN and RIDDLE 1984B ). We verified this and extended it by demonstrating that all alleles of egl-4 exhibit hypersensitivity to dauer pheromone (Fig 6A). While wild-type animals make <1% dauers upon addition of 1 µl of dauer pheromone, at this concentration nearly 100% of egl-4(n479) animals form dauers. By this assay, the strengths of alleles are as follows: n479 > ky27, n579, n477 > n612 > n478, ky185. We note that this allelic order differs from that found for the response to volatile odorants.

View larger version (15K): In this window In a new window Download PPT slide   Figure 6. Dauer formation phenotypes of egl-4 mutants. (A) The number of dauers formed at different concentrations of added pheromone is shown as a percentage of the total number of animals on the plate. Approximately 100–200 animals were counted at each concentration of pheromone. (B) Shown are the number of dauers formed after 2 days at 27°. See MATERIALS AND METHODS for additional details. Approximately 100 animals of each genotype were counted. Numbers shown are from a single experiment. Experiments repeated on independent days show similar relative differences.

Mutations in other Daf-c genes also result in hypersensitivity to dauer pheromone (GOLDEN and RIDDLE 1984B ; THOMAS et al. 1993 ). However, unlike most of these mutants, which are strongly Daf-c at 25°, all egl-4 alleles except n479 form few or no dauers under noninducing conditions at this temperature. n479 exhibits a weak Daf-c phenotype at 25° (Fig 6A). Dauer formation is modulated by temperature, and it has been shown previously that several mutants with weak Daf-c phenotypes at 25° are strongly Daf-c at the elevated temperature of 27° (AILION et al. 1999 ). Such mutants include unc-31, unc-64, and unc-3 (AILION et al. 1999 ). We examined the Daf-c phenotypes of egl-4 mutants at 27°. As shown in Fig 6B, all egl-4 alleles exhibit a Daf-c phenotype to varying degrees at 27°. n479 is the strongest allele, forming close to 100% dauers at 27°, while ky185 is the weakest allele, forming <25% dauers. The allelic series with respect to dauer formation at 27° is roughly similar to that determined by pheromone hypersensitivity.

egl-4 is Syn-Daf with unc-3:
Many weak Daf-c mutants have a Syn-Daf phenotype in double mutant combinations with unc-31, unc-64, and unc-3 mutants (I. KATSURA, personal communication; AILION et al. 1999 ). We wished to determine if egl-4 mutants are also Syn-Daf. egl-4 unc-31 and unc-64; egl-4 double mutants do not show Syn-Daf phenotypes (M. AILION and J. H. THOMAS, data not shown; I. KATSURA, personal communication). However, we find that the egl-4(n478); unc-3(e151) double mutant is strongly Syn-Daf, forming nearly 100% dauers at all temperatures (see Table 5). unc-3 has been shown to regulate the expression of the DAF-7 TGF-ß ligand (M. AILION and J. H. THOMAS, unpublished results; P. REN and D. RIDDLE, personal communication). We examined the expression of a daf-7::GFP fusion gene in egl-4(n478) mutants, and found that unlike unc-3 mutants, mutations in egl-4 do not affect expression of the DAF-7 TGF-ß ligand (data not shown).

Serotonin acts in parallel to egl-4 to regulate dauer formation:
egl-4 mutants exhibit a subset of the phenotypes associated with those of mutants with defects in serotonin signaling. For example, tph-1 tryptophan hydroxylase mutants that fail to synthesize serotonin have egg-laying defects and a weak Daf-c phenotype similar to that of egl-4 mutants (SZE et al. 2000 ). Serotonin has also been implicated in regulating foraging behavior and male mating (LOER and KENYON 1993 ; DUERR et al. 1999 ). We examined egl-4 mutants and found that they also have foraging and male mating defects (data not shown). This raised the possibility that egl-4 mutants have defects in serotonin signaling. The defects of tph-1 mutants can be rescued by the addition of exogenous serotonin (SZE et al. 2000 ). Although serotonin does not completely rescue the egg-laying defect of egl-4 mutants (see above), we tested whether exogenous serotonin could rescue the 27° Daf-c phenotype of the egl-4(n479) mutant. As shown in Fig 7A, serotonin does not rescue the 27° Daf-c phenotype of egl-4, unc-64, unc-31, or unc-3 mutants. However, serotonin does appear to enhance dauer recovery of these mutants. Exogenous serotonin leads to a dose-dependent increase in dauer recovery of egl-4, unc-64, and unc-3 mutants, and to a lesser extent of unc-31 mutants (Fig 7B). This suggests that the effect of serotonin on dauer recovery is not specific to egl-4.

View larger version (22K): In this window In a new window Download PPT slide   Figure 7. egl-4 mutants and serotonin. (A) Shown is the percentage of dauers formed at 27° in the presence of 5 mg/ml serotonin in the plate. A total of 100–200 animals of each genotype were counted in two independent assays. (B) The number of dauers on plates containing serotonin were counted after 4 days at 27° to assay recovery. Wild-type animals recover in 1 day at 27° in the presence or absence of serotonin.

To determine if serotonin acts in parallel to egl-4, we analyzed double mutants with tph-1 (Table 2). Dauer formation is enhanced in a tph-1; daf-7 double mutant, suggesting that tph-1 acts in parallel to the group II Daf-c pathway (SZE et al. 2000 ). Similarly, we find that the Daf-c phenotype of a tph-1; egl-4 double mutant is also strongly enhanced at all temperatures tested, indicating that tph-1 acts in parallel to egl-4 (Table 2). tph-1 mutants also enhance dauer formation of unc-31, unc-64, and unc-3 mutants, suggesting that tph-1 acts in parallel to these genes as well. We find that the tph-1; unc-31 and tph-1; unc-64 double mutants are no longer temperature sensitive for dauer formation, while the tph-1; egl-4 double mutant is weakly temperature sensitive.

egl-4 mutants exhibit synaptic transmission defects:
unc-64 and unc-31 encode proteins that mediate synaptic transmission and other types of Ca²⁺-regulated secretion (LIVINGSTONE 1991 ; AVERY et al. 1993 ; ANN et al. 1997 ; OGAWA et al. 1998 ; SAIFEE et al. 1998 ). Like egl-4, both mutants have multiple behavioral pleiotropies and are Syn-Daf. unc-64 and unc-31 are resistant to aldicarb, an inhibitor of acetylcholinesterase, indicating that these genes play a role in cholinergic transmission (NGUYEN et al. 1995 ; MILLER et al. 1996 ; SAIFEE et al. 1998 ). To test whether egl-4 also plays a role in synaptic transmission, we examined the effects of acute exposure of egl-4 mutants to aldicarb. In Fig 8A, we show that the n479 and n612 mutants of egl-4 are strongly resistant to aldicarb while the ky27 mutant is less resistant. We also find that unc-3(e151) mutants are strongly resistant to aldicarb. In addition to the quantitative measurement of aldicarb resistance, egl-4 mutants are qualitatively less hypercontracted than wild-type animals on aldicarb.

View larger version (15K): In this window In a new window Download PPT slide   Figure 8. Pharmacological analysis of synaptic transmission. (A) egl-4 mutants are resistant to aldicarb. The number of animals that are paralyzed on plates containing aldicarb is shown as a percentage of the total number of animals. Paralysis (defined as the absence of any movement or pumping when prodded) was scored after 10 hr on 0.5 mM aldicarb. Approximately 40 animals were counted for each genotype. (B) egl-4 mutants are sensitive to levamisole. Paralysis on 100 µM levamisole was scored every 30 min. Approximately 40 animals were counted for each genotype.

Resistance to aldicarb can arise either from a defect in presynaptic ACh synthesis or release, or from defects in the postsynaptic response to ACh. To determine whether egl-4 functions presynaptically or postsynaptically, we assayed sensitivity to the nicotinic ACh receptor agonist levamisole (LEWIS et al. 1980A , LEWIS et al. 1980B ). A postsynaptic mutant unc-29(e1072) is completely resistant to levamisole (FLEMING et al. 1997 ), whereas the unc-31(e928) mutant, which is involved in presynaptic release mechanisms, is sensitive. All three alleles of egl-4 tested are sensitive to levamisole, as are unc-3(e151) mutants, suggesting that egl-4 functions presynaptically in regulating synaptic transmission (Fig 8B). egl-4 mutants also appear to be hypersensitive to levamisole, similar to unc-31 mutants. However, unlike unc-31 mutants, egl-4 mutants exhibit adaptation at later time points, such that paralyzed animals resume pumping and slight movements of the nose.

egl-4 mutants have increased body length:
Body length in C. elegans is regulated via a DPP/BMP-mediated signaling pathway (SAVAGE et al. 1996 ; PADGETT et al. 1998 ; PATTERSON and PADGETT 2000 ). This pathway is similar to the TGF-ß-mediated branch of the dauer pathway, but uses a different ligand and an independent set of receptors and SMAD signaling genes with the exception of the DAF-4 TGF-ß type II receptor, which is shared by both pathways. daf-4 mutants are Daf-c and have reduced body length (ESTEVEZ et al. 1993 ). In contrast, we noted that egl-4 alleles cause increased body length (Fig 9). egl-4 mutants are 20–30% longer than wild-type animals. n579 mutants show the strongest defect, being on average 31% longer than wild type, while the n477 and n612 mutants show the weakest phenotypes, being 17% longer. In comparison, lon-2(e678) mutants, which have been implicated in the pathway regulating body length, are 34% longer than wild-type animals.

View larger version (16K): In this window In a new window Download PPT slide   Figure 9. egl-4 mutants have increased body length. The mean body length (in millimeters) is shown for animals of the indicated genotypes. At least 30 adult animals of each genotype were measured under 100x magnification using Nomarski optics and an eyepiece micrometer. Animals were measured 24 hr after the final molt. The mean body length of each egl-4 mutant is different from that of wild type at P < 0.001.

egl-4 functions in the group II branch of the dauer signaling pathway:
Three parallel pathways that regulate dauer formation have been identified (see Introduction). In addition to the Daf-c phenotype, egl-4 mutants share additional phenotypes in common with both group I and group II Daf-c genes. Group I Daf-c mutants exhibit chemosensory defects to volatile and water-soluble chemicals, while group II Daf-c genes have defects in egg laying, have dark intestines (Din), and exhibit a "clumpy" behavior, in which animals tend to congregate in clumps (TRENT et al. 1983 ; THOMAS 1993 ; VOWELS and THOMAS 1994 ; RIDDLE and ALBERT 1997 ). egl-4 mutants, in addition to having chemosensory and egg-laying defects, are also Din, but exhibit little if any clumpy behavior. To determine the pathway in which egl-4 functions, we made double mutants between egl-4 and mutations in each of these pathways. We examined suppression or enhancement of different phenotypes of egl-4 in these double mutants.

Dauer formation: The Daf-c phenotype of mutants that function in the group II pathway is fully suppressed by daf-3 and daf-5 mutations, while those in the other branches are not (THOMAS et al. 1993 ). We first tested whether the dauer formation defects of egl-4 mutants are suppressed by daf-3 and daf-5. We found that mutations in either daf-3 or daf-5 completely suppress egl-4 dauer formation induced by pheromone (Table 3), suggesting that egl-4 functions in the group II pathway of dauer formation. We also assayed suppression of the Daf-c phenotype of the strong n479 allele at 27°. The Daf-c phenotype of n479 is suppressed by mutations in the Daf-d genes daf-3, daf-5, daf-16, and daf-12 (Table 4). daf-12 mutations suppress the dauer phenotypes of Daf-c mutants in all three branches, since these branches are thought to converge at daf-12 (RIDDLE and ALBERT 1997 ; ANTEBI et al. 1998 ). daf-16 mutations have been shown to suppress the 27° Daf-c phenotypes of mutants in different branches of the pathway (AILION et al. 1999 ; APFELD and KENYON 1999 ). However, while dauer formation in unc-31 and unc-64 mutants is also suppressed by mutations in daf-12 and daf-16, the Daf-c phenotype of these mutants is not suppressed by daf-3 and daf-5 (AILION et al. 1999 ). In contrast, as shown in Table 4, dauer formation in egl-4 mutants at 27° is strongly suppressed by daf-3 and daf-5 mutations, further confirming placement of egl-4 in the group II pathway. Interestingly, egl-4 and daf-3 appear to mutually suppress each other, since while the daf-3(e1376) mutant and egl-4(n479) each form dauers at 27°, the egl-4; daf-3 double mutant makes fewer dauers than either single mutant alone. Mutations in the Daf-d gene osm-6, which also lead to a Daf-c phenotype at 27° (M. AILION and J. H. THOMAS, unpublished results; APFELD and KENYON 1999 ), do not suppress egl-4, demonstrating that such mutual suppression is specific to daf-3.

We also determined whether the Syn-Daf phenotype of the egl-4; unc-3 double mutant is suppressed by mutations in daf-5 and daf-16. We find that mutations in daf-5 completely suppress the egl-4(n478); unc-3(e151) synthetic dauer phenotype at either 15° or 25°, while daf-16 mutations fail to suppress at 25° and only weakly suppress at 15° (Table 5). These results further support placement of egl-4 in the group II branch.

Since dauer formation is regulated by parallel pathways, there is strong enhancement of the Daf-c phenotype in double mutants between genes in different pathways, but not between those acting in the same pathway (see Fig 1). For instance, while the Daf-c phenotypes of daf-8 and daf-11 mutants are incompletely penetrant at low temperatures, a daf-8; daf-11 double mutant forms 100% dauers (THOMAS et al. 1993 ). In contrast, the phenotype of a daf-8; daf-14 double mutant is still incompletely penetrant since both of these genes function in the TGF-ß pathway (THOMAS et al. 1993 ). To further confirm that egl-4 functions in the group II pathway, we built double mutants of egl-4 with Daf-c mutations in different pathways and looked for enhancement of the Daf-c phenotype at 15°. At this temperature, egl-4 clearly enhances the Daf-c phenotypes of daf-11(sa195) and tax-4(ks11) (group I genes; Table 6). Although egl-4 does not enhance the Daf-c phenotype of daf-2(e1370) (a member of the third branch) at 15°, there is significant enhancement at 20°. These results suggest that egl-4 acts in parallel to the group I branch and the daf-2 branch. We find that dauer formation is also slightly increased in egl-4(n478); daf-7(e1372) and egl-4(n478); daf-14(m77) double mutants (Table 6). This is difficult to interpret since daf-7 and daf-14 are strongly Daf-c on their own at 15°. However, in both cases it appears that egl-4 does enhance the phenotype, suggesting that egl-4 may act at least partially in parallel to the TGF-ß pathway, as well as the other two pathways. Since we do not know the molecular nature of the egl-4(n478) allele, it is formally possible that the enhancement observed in the double mutants is due to the nonnull nature of this allele.

Chemosensory behaviors: Group I Daf-c mutants exhibit numerous chemosensory defects (VOWELS and THOMAS 1994 ; COBURN and BARGMANN 1996 ). Group I genes such as daf-11 encode components of a cGMP-mediated signaling pathway that function both in dauer formation as well as other chemosensory processes (BIRNBY et al. 2000 ). To date, no genes in the TGF-ß or the insulin pathway have been implicated in other chemosensory pathways (TRENT et al. 1983 ; REN et al. 1996 ; SCHACKWITZ et al. 1996 ; SZE et al. 2000 ; TISSENBAUM et al. 2000 ). We further examined whether the chemosensory defects of egl-4(n478) are suppressed by daf-3 and daf-5 mutations. We find that daf-3(e1376) completely suppresses all olfactory defects of egl-4(n478) (Fig 10). However, the effects of daf-5 mutations are more specific. While daf-5(e1385) suppresses defects in behaviors mediated by the AWC olfactory neurons, it fails to suppress the diacetyl olfactory defect of egl-4, mediated by the AWA neurons. Interestingly, while neither daf-3 nor daf-5 mutants exhibit any olfactory defects of their own, daf-5(e1385) appears to enhance the relatively weak pyrazine response defect of n478. It is possible that this enhancement is specific for the e1385 allele of daf-5.

View larger version (23K): In this window In a new window Download PPT slide   Figure 10. Chemosensory phenotypes of egl-4 mutants are suppressed by daf-3 and daf-5 mutations. Chemotaxis indices between 0 and 1.0 have been divided into 11 equal-sized bins and assigned a circle of size indicated at the bottom. Open circles represent a negative chemotaxis index; filled circles represent a positive chemotaxis index. Each data point represents the mean of at least three independent assays of 200 animals each. Concentrations of odorants used are as indicated in Fig 3 and Fig 4. The alleles indicated for each single mutant are present in the double mutant strains. Responses significantly different from that of wild type at P < 0.01 are indicated by an asterisk next to the circle.

To determine if mutations in other branches can also suppress the chemosensory behavioral phenotypes, we examined the sensory behaviors of double mutants between egl-4 and the Daf-d mutations daf-16(mgDf50) and osm-3(p802). Interestingly, we find that daf-16(mgDf50) exhibits chemosensory behavioral defects on its own (Fig 10). daf-16 mutants show severely reduced responses to the odorants butanone and isoamyl alcohol, and exhibit significantly reduced responses to pyrazine and trimethylthiazole. This is not specific to the daf-16(mgDf50) allele, since daf-16(m27) mutants show similar defects (data not shown). Unlike daf-3 and daf-5, daf-16 mutations fail to significantly suppress any chemosensory defects of egl-4(n478) (Fig 10). However, like egl-4(n478); daf-5(e1385) double mutants, the egl-4(n478); daf-16(mgDf50) double mutant shows an enhancement of the defect in the response to pyrazine. The osm-3 mutation also largely fails to suppress the chemosensory defects of egl-4 mutants, showing only weak partial suppression for the response to butanone. Finally, we also examined the responses of egl-4(n478); daf-12(m20) double mutants. Although daf-12 mutations suppress the Daf-c phenotypes of mutants in all three branches of the dauer pathway, it has been shown previously that daf-12 fails to suppress other pleiotropies (THOMAS 1993 ; RIDDLE and ALBERT 1997 ; ANTEBI et al. 1998 ), suggesting that daf-12 is the point of convergence only for the dauer pathway. Consistent with this, we find that daf-12 fails to suppress any of the behavioral defects of egl-4 mutants. Surprisingly, we also find that daf-12(m20) single mutants show strong defects in the response to butanone (Fig 10). These results provide additional evidence to indicate that egl-4 functions in the group II pathway, upstream of daf-3 and daf-5.

Egg-laying behavior: It has been shown previously that in addition to suppressing the Daf-c phenotype, daf-3 and daf-5 mutants suppress other pleiotropies of group II Daf-c genes. These include the egg-laying defect, the Din phenotype, and the clumpy behavior (TRENT et al. 1983 ; VOWELS and THOMAS 1994 ). We reexamined whether the egg-laying defect of egl-4 mutants is suppressed by daf-3 and daf-5 mutations, and also determined whether this defect can be suppressed by mutations in other branches of the pathway. As shown in Fig 11A, we find that both daf-3(e1376) and daf-5(e1385) partially suppress the egg-laying defect of egl-4(n478) mutants. In contrast, osm-3, daf-16, and daf-12 double mutants clearly show less suppression. Qualitative examination also indicates that the Din phenotype of egl-4 is suppressed by daf-3 and daf-5, but not by daf-16, daf-12, or osm-3 (data not shown).

View larger version (21K): In this window In a new window Download PPT slide   Figure 11. daf-3 and daf-5 suppress the altered body length and egg-laying phenotypes of egl-4. (A) The number of eggs in the uterus of animals of the indicated genotypes was counted. n 20 for each genotype. Asterisks denote differences from wild type at P < 0.01. (B) The mean lengths in millimeters of adult hermaphrodites are shown. At least 20 animals of each genotype were measured. Mean body lengths of single and double mutants that are significantly different (P < 0.001) from that of wild-type animals are indicated by an asterisk.

Body length: Mutations in the DAF-4 TGF-ß receptor cause small body length, yet this defect is not suppressed by daf-3 and daf-5 mutations (VOWELS and THOMAS 1992 ). An independent set of SMAD genes functions downstream of DAF-4 to mediate body size regulation (SAVAGE et al. 1996 ; PADGETT et al. 1998 ). Since daf-3 and daf-5 suppress all phenotypes of egl-4 tested, we wished to determine if the increased body length phenotype could also be suppressed by daf-3 and daf-5 mutations. We found that daf-3(e1376) fully suppresses the increased body length of egl-4(n478) (P > 0.03 compared to wild type), whereas this phenotype is only partially suppressed by daf-5(e1385) (Fig 11B). We find that daf-16(mgDf50) and osm-3(p802) also show weak suppression. As reported previously, daf-12(m20) single mutants show dramatically increased body length (THOMAS et al. 1993 ), and we find that daf-12 mutants are on average 21% longer than wild-type animals. The effects of mutations in egl-4 and daf-12 are partially additive for body length since the egl-4; daf-12 double mutant is significantly longer than either single mutant (P < 0.001; Fig 11B). Taken together, these results are strongly consistent with the placement of egl-4 in the group II pathway, either together with the TGF-ß Daf-c genes or partially in parallel.

egl-32 may function in the same pathway as egl-4:
A single egl-32 allele (n155) was isolated in the same screens that resulted in the isolation of egl-4 alleles (TRENT et al. 1983 ). egl-4 and egl-32 appear to function at least partly in similar pathways since it has been shown that (1) both egl-4 and egl-32 show similar variable responses to exogenous serotonin and imipramine (TRENT et al. 1983 ), (2) the egg-laying defects of both egl-32 and egl-4 mutants are suppressed by daf-3 and daf-5 mutations (TRENT et al. 1983 ), and (3) egl-4 and egl-32 are Syn-Daf with unc-3 mutations (I. KATSURA, personal communication). However, unlike egl-4, egl-32 is not hypersensitive to dauer pheromone and we find that egl-32 is not Daf-c at 27° (M. AILION and J. H. THOMAS, unpublished results; GOLDEN and RIDDLE 1984B ). In addition, egl-32(n155) does not enhance the Daf-c phenotype of egl-4(n478) (data not shown).

Since egl-4 mutants exhibit strong chemosensory defects, we examined the chemosensory behaviors of egl-32(n155) mutants. We find that egl-32 mutants show strong chemosensory defects in the responses mediated by the AWC neurons, with weak defects in the responses to odorants sensed by the AWA neurons (Fig 12). egl-32 mutants also exhibit weak defects in the responses to NaCl and lysine (data not shown). The chemosensory defects of egl-32; egl-4 double mutants do not appear to be significantly stronger than either mutant alone with the exception of partial enhancement of defects in the responses to 2,3-pentanedione and trimethylthiazole. This suggests that egl-32 functions partially in parallel to egl-4 with respect to some chemosensory behaviors. We also find that daf-3 and daf-5 suppress the olfactory defects of egl-32 mutants with the daf-5(e1385) mutation suppressing more strongly than the daf-3(e1376) mutation (Fig 12). Although these data should be interpreted with caution since only one mutant allele of egl-32 is available, the phenotypic analyses suggest that egl-4 and egl-32 may function partly similarly to regulate dauer formation, and chemosensory and egg-laying behaviors.

View larger version (21K): In this window In a new window Download PPT slide   Figure 12. egl-32 mutants show chemosensory defects that are suppressed by daf-3 and daf-5. The representation of the data is as described for Fig 10. Each data point represents the mean of at least three independent assays of 200 animals each. Responses significantly different from that of wild type at P < 0.01 are indicated by an asterisk next to the circle.

	DISCUSSION

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION LITERATURE CITED

egl-4 mutants show a number of behavioral and developmental abnormalities, including defective chemosensation and dauer formation, defective egg laying, altered body size, and defective synaptic transmission. Most phenotypes of egl-4 mutants are suppressed by mutations in the daf-5 and daf-3 (encoding a SMAD protein) genes, suggesting that egl-4 functions through the group II branch of the dauer formation pathway to regulate multiple functions. We propose that egl-4 acts to relay sensory cues to modulate different neuronal signaling pathways.

egl-4 mutant phenotypes arise from defects in neuronal function:
We have shown that mutations in egl-4 result in multiple behavioral and developmental abnormalities. These include defects in egg-laying behavior, chemosensory perception, dauer formation, and regulation of body size. These defects could, in principle, arise from functions of egl-4 in multiple tissue types. However, taken together, analyses of egl-4 phenotypes presented here indicate that the focus of egl-4 action is primarily neuronal. We provide several lines of evidence in support of this hypothesis.

All behavioral and developmental pathways affected by egl-4 mutations are regulated by neuronal inputs. Environmental cues are sensed by sensory neurons. Signals are then relayed to interneurons where integration of these signals occurs (for example, see MORI and OHSHIMA 1995 ). Interneurons then relay this information to target tissues. The relatively specific chemosensory defects of egl-4 mutants point to a deficit in sensory signaling, or perhaps integration, rather than a general defect in target tissues. This is also consistent with the effects of egl-4 mutations on dauer formation. The target of the DAF-7 TGF-ß ligand in dauer formation is thought to be neuronal (INOUE and THOMAS 2000 ). The coordinated developmental changes that occur throughout the animal in response to dauer cues indicate that integration of dauer-forming signals occurs in neurons, and a coordinated and integrated signal is then sent to additional tissue types. Mosaic analysis has shown that the DAF-4 TGF-ß type II receptor functions nonautonomously in the nervous system for dauer formation (INOUE and THOMAS 2000 ). Work presented here suggests that egl-4 functions with or partially in parallel to the group II Daf-c genes (see below), suggesting that egl-4 may also function in neurons.

Egg-laying behavior is also regulated by neuronal inputs. Serotonin is released primarily by the HSN neurons and allows egg-laying muscles to enter into an active state (HORVITZ et al. 1982 ; TRENT et al. 1983 ; DESAI et al. 1988 ; WEINSHENKER et al. 1995 ; WAGGONER et al. 1998 ). Within the active state, ACh released by both the HSN and VC motor neurons promotes egg laying by excitation of egg-laying muscles (WAGGONER et al. 1998 ). The action of serotonin is potentiated by flp-1-encoded neuropeptides, which may act to relay sensory cues to the egg-laying machinery (WAGGONER et al. 2000 ). Analysis of the egg-laying pattern of egl-4 mutants indicates that egl-4 is deficient in the induction of the active egg-laying phase, similar to serotonergic mutants as well as flp-1 mutants (WAGGONER et al. 1998 , WAGGONER et al. 2000 ). Similar to flp-1 mutants, egl-4 mutants are also unable to regulate their rate of egg laying in response to food cues. flp-1 is expressed in interneurons that integrate sensory information (SCHINKMANN and LI 1992 ). The defects of egl-4 are consistent with a role for egl-4 in sensory neurons and/or interneurons to integrate or relay sensory signals.

Body size may also be regulated by signals from neurons. The DBL-1 DPP/BMP-like signal that regulates body size is expressed in neurons (SUZUKI et al. 1999 ). This signal is then transduced to other tissue types such as the hypodermis to regulate body size. egl-4 could function in neurons to modulate body size regulatory signals.

Finally, we have shown that egl-4 mutants are resistant to the acetylcholinesterase inhibitor aldicarb. This is a characteristic of genes that function at cholinergic synapses (MILLER et al. 1996 ). Mutations in presynaptic genes such as unc-17, which encodes the vesicular ACh transporter, and cha-1, which encodes the choline acetyltransferase, are also aldicarb resistant due to reduced or absent ACh at the neuromuscular junction (ALFONSO et al. 1993 , ALFONSO et al. 1994 ). unc-29 mutants are also aldicarb resistant since unc-29 encodes the subunit of the nicotinic ACh receptor, which functions postsynaptically in target muscles (FLEMING et al. 1997 ). However, we show that unlike unc-29 mutants, egl-4 mutants are levamisole sensitive, similar to unc-17 and cha-1. This strongly indicates that the focus of egl-4 function is neuronal. The relatively restricted phenotypes of egl-4 mutants suggest that egl-4 is required for function rather than development of the nervous system.

egl-4 and neurotransmitters:
Our results indicate that egl-4 functions presynaptically, at least in cholinergic neurons. Both ACh and serotonin have been implicated in regulating dauer formation and recovery (SZE et al. 2000 ; TISSENBAUM et al. 2000 ). This raises the possibility that egl-4 plays a role in the release or synthesis of neurotransmitters such as ACh or serotonin. In general, mutants with strong defects in ACh synthesis or release at the neuromuscular junction show movement abnormalities and are uncoordinated. These include unc-17, cha-1, unc-31, unc-3, and unc-64. unc-3 encodes a transcription factor that is required for the expression of unc-17 and cha-1 in cholinergic motor neurons (K. LICKTEIG and D. MILLER, personal communication). unc-31 and unc-64 may be required for exocytosis of ACh. However, egl-4 mutants show no gross movement defects. It is possible that egl-4 affects ACh synthesis or release but to a lesser degree such that in egl-4 mutants the level of ACh released is sufficient to excite muscles, but insufficient to mediate the paralyzing effects of aldicarb. ACh regulates the frequency of egg laying in the active phase, and cha-1 mutations result in a decrease in the frequency of egg laying within the active phase (WAGGONER et al. 1998 ). The frequency of egg laying in the active phase is unaffected in egl-4 mutants, consistent with a minor effect of egl-4 mutations on ACh release.

egl-4 mutants share a subset of defects found in mutants defective in serotonin signaling. These include defects in egg laying, foraging, male mating, and effects on dauer formation. However, our results suggest that egl-4 is not directly involved in the serotonergic pathway. First, added serotonin fails to fully rescue the egg-laying defects or dauer formation defects of egl-4 mutants. Rescue by serotonin would be expected if egl-4 functions presynaptically in serotonin signaling. Second, we find that the Daf-c phenotype of egl-4; tph-1 mutants is strongly enhanced, suggesting that tph-1 functions in parallel to egl-4 and not in the same pathway. Third, serotonin has been shown to inhibit ACh release at the neuromuscular junction (LACKNER et al. 1999 ; MILLER et al. 1999 ; NURRISH et al. 1999 ). Mutants with defects in the serotonin pathway exhibit hyperactivity and are aldicarb hypersensitive due to excessive release of ACh. egl-4 mutants, on the other hand, show no movement defects and are aldicarb resistant. These results suggest that egl-4 does not directly function in the serotonin pathway. However, it remains formally possible that egl-4 has weak effects in both the serotonergic pathway and the cholinergic pathway.

egl-4 and the group II Daf-c genes:
egl-4 shares a number of phenotypic similarities with group II Daf-c genes. In addition to effects on dauer formation, these include defects in egg laying and a darkened intestine. However, the phenotypes of group II and egl-4 mutants are not identical. Group II mutants (with the exception of daf-4 mutants) also exhibit a clumpy behavior, a trait not exhibited by egl-4 mutants. In addition, egl-4 mutants have increased body size whereas among the group II genes, only daf-4 has altered body size. Unlike egl-4 mutants, daf-4 mutants are smaller than wild type. Also, while the egg-laying phenotype of egl-4 is variably sensitive to serotonin and imipramine, egg laying by the group II Daf-c mutants is sensitive to both of these agents (TRENT et al. 1983 ). egl-4 mutants also share some behavioral defects in common with group I genes in that egl-4 mutants exhibit strong defects in chemosensory behaviors. No group II Daf-c genes show significant defects in chemosensation (S. DANIELS and P. SENGUPTA, unpublished results; VOWELS and THOMAS 1994 ), although this behavior is difficult to measure due to their clumpy phenotype. It should be noted that the PDK-1 Akt/PKB kinase that functions in the insulin pathway also shares some mutant phenotypes with egl-4 and group II genes, including increased body size, egg-laying defects, and clumpy behavior (PARADIS et al. 1999 ). These phenotypes are suppressed by daf-16 mutations, but not by daf-5, osm-6, or daf-12 mutations (PARADIS et al. 1999 ).

The strongest evidence that egl-4 functions in the group II branch of the pathway is the fact that many phenotypes of egl-4, including chemosensory, dauer formation, egg laying, and body size defects, are suppressed by mutations in daf-3 and daf-5, but not by group I Daf-d or by daf-16 mutations. This is a characteristic of group II genes, since Daf-c genes in group I or the insulin pathways are not fully suppressed by daf-3 and daf-5. However, daf-3 and daf-5 mutations fail to suppress the aldicarb resistance phenotype of egl-4 mutants (data not shown).

The TGF-ß branch appears to act partly in parallel to serotonin, since dauer arrest of daf-7 mutants is strongly enhanced by tph-1 mutations (SZE et al. 2000 ). We have shown that egl-4 and serotonin also act in parallel, since the dauer formation phenotype of egl-4 mutants is also enhanced by tph-1 mutations. This is consistent with a role for egl-4 in the group II branch. It is also possible that egl-4 functions partly in parallel to the TGF-ß pathway with outputs to daf-3 and daf-5. This possibility could explain the fact that there appears to be some enhancement of the Daf-c phenotype of egl-4(n478) in double mutant combinations with group II Daf-c mutants such as daf-7 and daf-14.

The Daf-d genes daf-3, daf-5, daf-16, and daf-12 function in chemosensation:
In addition to affecting dauer formation, genes involved in the TGF-ß branch also regulate other aspects of nondauer development as is evident from pleiotropies in the mutants. Since all pleiotropies are suppressed by daf-3 and daf-5 mutations, daf-3 and daf-5 may function in multiple tissue types to antagonize the TGF-ß pathway. The DAF-3 SMAD protein is expressed in multiple tissue types including neurons, pharynx, hypodermis, and intestine; these tissues are extensively remodeled during the dauer stage (PATTERSON et al. 1997 ). It has been shown that DAF-3 represses gene expression in the pharynx by directly binding upstream of gene sequences (THATCHER et al. 1999 ). Remarkably, we find that daf-3 and daf-5 mutations also suppress chemosensory defects of egl-4 mutants. This suggests that daf-3 and daf-5 function downstream of egl-4 to integrate or modulate chemosensory information. However, since the egl-4 allele used in these experiments could be nonnull, we are unable to rule out the possibility that daf-3 and daf-5 act upstream of egl-4. In either case, this is an unexpected finding since neither daf-3 and daf-5 nor the group II Daf-c genes exhibit chemosensory defects on their own (this work; VOWELS and THOMAS 1994 ). We show that there appear to be some differences in the degree of suppression of egl-4(n478) by daf-3(e1376) and daf-5(e1385) with respect to different phenotypes. For example, daf-5(e1385) enhances the pyrazine defects of egl-4(n478), suggesting that daf-5 may function independently of the TGF-ß pathway in the response to pyrazine. Also, while daf-3 suppresses all chemosensory defects of egl-4, suppression by daf-5 is restricted to responses mediated by the AWC neurons. Interestingly, daf-5 appears to suppress egl-32(n155) defects more strongly, suggesting that the DAF-3 SMAD gene and DAF-5 may have unique functions as well as distinct sites of action in regulating chemosensory responses.

Daf genes in other branches affect aspects of C. elegans development other than dauer formation. For example, the insulin pathway regulates life span such that daf-2 mutants have extended life span (KENYON et al. 1993 ). This effect is suppressed by loss-of-function mutations in daf-16 (KENYON et al. 1993 ). We show that daf-16 and daf-12 Daf-d mutants also have chemosensory defects. This may occur due to deficits in downstream processing events, or possibly from defective regulation of genes directly involved in sensory perception. These results implicate these Daf-d genes in additional signaling pathways.

Model for egl-4 function:
The effect of egl-4 on different pathways clearly arises from deregulation of neuronal functions, several of which are regulated by sensory cues. These include chemosensory behaviors, dauer formation, foraging, and egg laying. Signals from food sources are attractive and they promote nondauer development, increase egg laying, and inhibit foraging. As initially proposed by TRENT et al. 1983 , it is possible that egl-4 is involved in relaying sensory cues to these pathways, thereby modulating these circuits.

Sensory cues are known to regulate each of the dauer formation pathways. daf-7 is expressed in the ASI neurons and is downregulated in response to high pheromone, low food, and high temperatures (REN et al. 1996 ; SCHACKWITZ et al. 1996 ). It is possible that these sensory cues are directly sensed by ASI to regulate daf-7 expression. However, it is also likely that cues sensed by other sensory neurons, in addition to ASI, are transmitted to regulate daf-7 expression (KOGA et al. 1999 ; SZE et al. 2000 ). Since we have not observed a direct effect on daf-7 expression in egl-4 mutants, egl-4 could act downstream of the daf-7 expression step by either modulating the action of DAF-7 and other TGF-ß pathway genes in response to environmental signals or by modulating the activity of the daf-3 and daf-5 genes.

Similarities between egl-4 and the Daf-c genes in the TGF-ß pathway suggest that these genes may act together or in parallel to relay sensory cues to the egg-laying circuit. Mutants in both egl-4 and the Daf-c genes in the TGF-ß pathway display egg-laying defects and exhibit long intercluster intervals (L. HARDAKER and W. SCHAFER, personal communication; TRENT et al. 1983 ; WAGGONER et al. 1998 ). In addition, similar to egl-4 mutants, egg laying by TGF-ß pathway Daf-c mutants is insensitive to food signals (L. HARDAKER and W. SCHAFER, personal communication). Finally, both daf-3 and daf-5 mutations suppress the egg-laying defects of all of these mutants (TRENT et al. 1983 ; THOMAS et al. 1993 ; this work). Based on these findings, we propose that egl-4 relays sensory cues to the egg-laying circuit through the activity of the TGF-ß pathway. This modulation may occur via direct or indirect regulation of the flp-1-encoded neuropeptides, or these genes could act in an independent pathway. Although egl-4 mutations are pleiotropic, it is unlikely that egl-4 affects some very general aspect of neuronal function. Other egg-laying mutants are not Daf-c and their phenotypes are not suppressed by daf-3 and daf-5. Thus, egl-4 perturbs a specific aspect of neuronal function.

Where does egl-4 act? It is interesting to note that egl-4 mutants show specific chemosensory defects. egl-4 shows strong defects in sensing diacetyl, but responds relatively well to pyrazine and trimethylthiazole, chemicals also sensed by the AWA neurons. Based on the numerous pleiotropies of egl-4 mutants, it is unlikely that egl-4 functions only in the primary chemosensory responses. It has been shown that animals adapted to one odorant continue to respond to other odorants sensed by the same neuron type (COLBERT and BARGMANN 1995 ). This could occur if, for instance, responses to different odorants resulted in the activation of distinct signaling pathways downstream of the sensory neuron. For example, the ASH sensory neurons use a glutamate-mediated pathway to respond to one type of stimulus, while other stimuli sensed by the same neurons appear to use a distinct mechanism (HART et al. 1995 ; MARICQ et al. 1995 ). It is possible that egl-4 functions similarly to mediate specific odorant response pathways. This would suggest that a site of egl-4 function could be interneurons. This is also consistent with its role in regulating egg laying, since flp-1 is known to be expressed in interneurons that integrate sensory signals (SCHINKMANN and LI 1992 ). We expect that elucidation of the molecular nature of egl-4 and its sites of action will reveal further information regarding its role in regulating development and behavior in C. elegans.

	FOOTNOTES

¹ These authors contributed equally to this work.

	ACKNOWLEDGMENTS

We thank Cori Bargmann in whose lab this work was initiated. We are grateful to Elizabeth Malone Link for advice and suggestions during the course of this work. We thank Don Riddle, David Miller, and Isao Katsura for permission to cite unpublished work; Bob Horvitz, Don Riddle, Chris Li, Gary Ruvkun, and the Caenorhabditis Genetics Center for providing us with strains; and the Sengupta lab for advice and ideas. We also thank Elizabeth Malone Link and Cori Bargmann for critical comments on the manuscript. This work was supported by National Institutes of Health grants GM56223 (P.S.) and GM48700 (J.T.), and funds from the Searle Scholar Foundation and Packard Foundation (P.S.). M.A. was supported by a Howard Hughes Medical Institute Predoctoral Fellowship.

Manuscript received April 6, 2000; Accepted for publication May 15, 2000.

	LITERATURE CITED

TOP ABSTRACT MATERIALS AND METHODS RESULTS DISCUSSION LITERATURE CITED

AILION, M. and J. H. THOMAS, 2000  Dauer formation induced by high temperatures in Caenorhabditis elegans. Genetics 156(2 in press).

AILION, M., T. INOUE, C. I. WEAVER, R. W. HOLDCRAFT, and J. H. THOMAS, 1999  Neurosecretory control of aging in Caenorhabditis elegans.. Proc. Natl. Acad. Sci. USA 96:7394-7397[Abstract/Free Full Text].

ALBERT, P. S., S. J. BROWN, and D. L. RIDDLE, 1981  Sensory control of dauer larva formation in Caenorhabditis elegans.. J. Comp. Neurol. 198:435-451[Medline].

ALFONSO, A., K. GRUNDAHL, J. S. DUERR, H. P. HAN, and J. B. RAND, 1993  The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter. Science 261:617-619[Abstract/Free Full Text].

ALFONSO, A., K. GRUNDAHL, J. R. MCMANUS, and J. B. RAND, 1994  Cloning and characterization of the choline acetyltransferase structural gene (cha-1) from C. elegans.. J. Neurosci. 14:2290-2300[Abstract].

ANN, K., J. A. KOWALCHYK, K. M. LOYET, and T. F. MARTIN, 1997  Novel Ca²⁺-binding protein (CAPS) related to UNC-31 required for Ca²⁺-activated exocytosis. J. Biol. Chem. 272:19637-19640[Abstract/Free Full Text].

ANTEBI, A., J. G. CULOTTI, and E. M. HEDGECOCK, 1998  daf-12 regulates developmental age and the dauer alternative in Caenorhabditis elegans.. Development 125:1191-1205[Abstract].

APFELD, J. and C. KENYON, 1999  Regulation of lifespan by sensory perception in Caenorhabditis elegans.. Nature 402:804-809[Medline].

AVERY, L. and H. R. HORVITZ, 1990  Effects of starvation and neuroactive drugs on feeding in Caenorhabditis elegans.. J. Exp. Zool. 253:263-270[Medline].

AVERY, L. A., C. I. BARGMANN, and H. R. HORVITZ, 1993  The Caenorhabditis elegans unc-31 gene affects multiple nervous system-controlled functions. Genetics 134:455-464[Abstract].

BARGMANN, C. I. and H. R. HORVITZ, 1991a  Chemosensory neurons with overlapping functions direct chemotaxis to multiple chemicals in C. elegans. Neuron 7:729-742[Medline].

BARGMANN, C. I. and H. R. HORVITZ, 1991b  Control of larval development by chemosensory neurons in Caenorhabditis elegans.. Science 251:1243-1246[Abstract/Free Full Text].

BARGMANN, C. I., J. H. THOMAS and H. R. HORVITZ, 1990 Chemosensory cell function in the behavior and development of Caenorhabditis elegans. Cold Spring Harbor Symp. Quant. Biol. LV: 529–538.

BARGMANN, C. I., E. HARTWIEG, and H. R. HORVITZ, 1993  Odorant-selective genes and neurons mediate olfaction in C. elegans. Cell 74:515-527[Medline].

BIRNBY, D. A., E. M. LINK, J. J. VOWELS, H. TIAN, and P. L. COLACURCIO et al., 2000  A transmembrane guanylyl cyclase (DAF-11) and Hsp90 (DAF-21) regulate a common set of chemosensory behaviors in C. elegans.. Genetics 155:85-104[Abstract/Free Full Text].

BRENNER, S., 1974  The genetics of Caenorhabditis elegans.. Genetics 77:71-94[Abstract/Free Full Text].

CHALFIE, M., J. E. SULSTON, J. G. WHITE, E. SOUTHGATE, and J. N. THOMSON et al., 1985  The neural circuit for touch sensitivity in Caenorhabditis elegans.. J. Neurosci. 5:956-964[Abstract].

COBURN, C. and C. I. BARGMANN, 1996  A putative cyclic nucleotide-gated channel is required for sensory development and function in C. elegans. Neuron 17:695-706[Medline].

COBURN, C. M., I. MORI, Y. OHSHIMA, and C. I. BARGMANN, 1998  A cyclic nucleotide-gated channel inhibits sensory axon outgrowth in larval and adult Caenorhabditis elegans: a distinct pathway for maintenance of sensory axon structure. Development 125:249-258[Abstract].

COLBERT, H. A. and C. I. BARGMANN, 1995  Odorant-specific adaptation pathways generate olfactory plasticity in C. elegans. Neuron 14:803-812[Medline].

COLBERT, H. A., T. L. SMITH, and C. I. BARGMANN, 1997  OSM-9, a novel protein with structural similarity to channels, is required for olfaction, mechanosensation, and olfactory adaptation in Caenorhabditis elegans.. J. Neurosci. 17:8259-8269[Abstract/Free Full Text].

DESAI, C., G. GARRIGA, S. L. MCINTIRE, and H. R. HORVITZ, 1988  A genetic pathway for the development of the Caenorhabditis elegans HSN motor neurons. Nature 336:638-646[Medline].

DRISCOLL, M., and J. KAPLAN, 1997 Mechanotransduction, pp. 645–677 in C. elegans II, edited by D. L. RIDDLE, T. BLUMENTHAL, B. MEYER and J. PRIESS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

DUERR, J. S., D. L. FRISBY, J. GASKIN, A. DUKE, and K. ASERMELY et al., 1999  The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. J. Neurosci. 19:72-84[Abstract/Free Full Text].

DUSENBERY, D. B., 1974  Analysis of chemotaxis in the nematode Caenorhabditis elegans by countercurrent separation. J. Exp. Zool. 188:41-47[Medline].

ESTEVEZ, M., L. ATTISANO, J. L. WRANA, P. S. ALBERT, and J. MASSAGUE et al., 1993  The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature 365:644-649[Medline].

FLEMING, J. T., M. D. SQUIRE, T. M. BARNES, C. TORNOE, and K. MATSUDA et al., 1997  Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and unc-38 encode functional nicotinic acetylcholine receptor subunits. J. Neurosci. 17:5843-5857[Abstract/Free Full Text].

GEORGI, L. K., P. S. ALBERT, and D. L. RIDDLE, 1990  daf-1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase. Cell 61:635-645[Medline].

GIL, E. B., E. M. LINK, L. X. LIU, C. D. JOHNSON, and J. A. LEES, 1999  Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc. Natl. Acad. Sci. USA 96:2925-2930[Abstract/Free Full Text].

GOLDEN, J. W. and D. L. RIDDLE, 1982  A pheromone influences larval development in the nematode Caenorhabditis elegans.. Science 218:578-580[Abstract/Free Full Text].

GOLDEN, J. W. and D. L. RIDDLE, 1984a  The Caenorhabditis elegans dauer larva: developmental effects of pheromone, food, and temperature. Dev. Biol. 102:368-378[Medline].

GOLDEN, J. W. and D. L. RIDDLE, 1984b  A pheromone-induced developmental switch in Caenorhabditis elegans: temperature-sensitive mutants reveal a wild-type temperature-dependent process. Proc. Natl. Acad. Sci. USA 81:819-823[Abstract/Free Full Text].

GOLDEN, J. W. and D. L. RIDDLE, 1985  A gene affecting production of the Caenorhabditis elegans dauer-inducing pheromone. Mol. Gen. Genet. 198:534-536[Medline].

GOTTLIEB, S. and G. RUVKUN, 1994  daf-2, daf-16 and daf-23: genetically interacting genes controlling dauer formation in Caenorhabditis elegans.. Genetics 137:107-120[Abstract].

HART, A., S. SIMS, and J. KAPLAN, 1995  Synaptic code for sensory modalities revealed by C. elegans GLR-1 glutamate receptor. Nature 378:82-85[Medline].

HERMAN, R. K. and E. M. HEDGECOCK, 1990  Limitation of the size of the vulval primordium of Caenorhabditis elegans by lin-15 expression in surrounding hypodermis. Nature 348:169-171[Medline].

HORVITZ, H. R., M. CHALFIE, C. TRENT, J. E. SULSTON, and P. D. EVANS, 1982  Serotonin and octopamine in the nematode Caenorhabditis elegans.. Science 216:1012-1014[Abstract/Free Full Text].

INOUE, T. and J. H. THOMAS, 2000  Targets of TGF-ß signaling in Caenorhabditis elegans dauer formation. Dev. Biol. 217:192-204[Medline].

JANSEN, G., K. L. THIJSSEN, P. WERNER, M. VAN DER HORST, and E. HAZENDONK et al., 1999  The complete family of genes encoding G proteins of Caenorhabditis elegans.. Nat. Genet. 21:414-419[Medline].

KAPLAN, J. and H. HORVITZ, 1993  A dual mechanosensory and chemosensory neuron in Caenorhabditis elegans.. Proc. Natl. Acad. Sci. USA 90:2227-2231[Abstract/Free Full Text].

KENYON, C., J. CHANG, E. GENSCH, A. RUDNER, and R. TABTIANG, 1993  A C. elegans mutant that lives twice as long as wild type. Nature 366:461-464[Medline].

KIMURA, K. D., H. A. TISSENBAUM, Y. LIU, and G. RUVKUN, 1997  daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans.. Science 277:942-946[Abstract/Free Full Text].

KOGA, M., M. TAKE-UCHI, T. TAMEISHI, and Y. OHSHIMA, 1999  Control of DAF-7 TGF-ß expression and neuronal process development by a receptor tyrosine kinase KIN-8 in Caenorhabditis elegans.. Development 126:5387-5398[Abstract].

KOMATSU, H., I. MORI, and Y. OHSHIMA, 1996  Mutations in a cyclic nucleotide-gated channel lead to abnormal thermosensation and chemosensation in C. elegans. Neuron 17:707-718[Medline].

LACKNER, M. R., S. J. NURRISH, and J. M. KAPLAN, 1999  Facilitation of synaptic transmission by EGL-30 Gq and EGL-8 PLCß: DAG binding to UNC-13 is required to stimulate acetylcholine release. Neuron 24:335-346[Medline].

LARSEN, P. L., P. S. ALBERT, and D. L. RIDDLE, 1995  Genes that regulate both development and longevity in Caenorhabditis elegans.. Genetics 139:1567-1583[Abstract].

LEWIS, J. A. and J. A. HODGKIN, 1977  Specific neuroanatomical changes in chemosensory mutants of the nematode Caenorhabditis elegans.. J. Comp. Neurol. 172:489-510[Medline].

LEWIS, J. A., C. H. WU, H. BERG, and J. H. LEVINE, 1980a  The genetics of levamisole resistance in the nematode Caenorhabditis elegans.. Genetics 95:905-928[Abstract/Free Full Text].

LEWIS, J. A., C. H. WU, J. H. LEVINE, and H. BERG, 1980b  Levamisole-resistant mutants of the nematode Caenorhabditis elegans appear to lack pharmacological acetylcholine receptors. Neuroscience 5:967-989[Medline].

LIN, K., J. B. DORMAN, A. RODAN, and C. KENYON, 1997  daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans.. Science 278:1319-1322[Abstract/Free Full Text].

LIU, D. W. and J. H. THOMAS, 1994  Regulation of a periodic motor program in C. elegans.. J. Neurosci. 14:1953-1962[Abstract].

LIVINGSTONE, D., 1991 Studies on the unc-31 gene of Caenorhabditis elegans. Ph.D. Dissertation, University of Cambridge.

LOER, C. M. and C. J. KENYON, 1993  Serotonin-deficient mutants and male mating behavior in the nematode Caenorhabditis elegans.. J. Neurosci. 13:5407-5417[Abstract].

MARICQ, A. V., E. PECKOL, and C. I. BARGMANN, 1995  Mechanosensory signalling in C. elegans mediated by the GLR-1 glutamate receptor. Nature 378:78-81[Medline].

MILLER, K. G., A. ALFONSO, M. NGUYEN, J. A. CROWELL, and C. D. JOHNSON et al., 1996  A genetic selection for Caenorhabditis elegans synaptic transmission mutants. Proc. Natl. Acad. Sci. USA 93:12593-12598[Abstract/Free Full Text].

MILLER, K. G., M. D. EMERSON, and J. B. RAND, 1999  Go and diacylglycerol kinase negatively regulate the Gq pathway in C. elegans. Neuron 24:323-333[Medline].

MORI, I. and Y. OHSHIMA, 1995  Neural regulation of thermotaxis in Caenorhabditis elegans.. Nature 376:344-348[Medline].

MORRIS, J. Z., H. A. TISSENBAUM, and G. RUVKUN, 1996  A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans.. Nature 382:536-539[Medline].

NGUYEN, M., A. ALFONSO, C. D. JOHNSON, and J. B. RAND, 1995  Caenorhabditis elegans mutants resistant to inhibitors of acetylcholinesterase. Genetics 140:527-535[Abstract].

NURRISH, S., L. SEGALAT, and J. M. KAPLAN, 1999  Serotonin inhibition of synaptic transmission: G(0) decreases the abundance of UNC-13 at release sites. Neuron 24:231-242[Medline].

OGAWA, H., S. HARADA, T. SASSA, H. YAMAMOTO, and R. HOSONO, 1998  Functional properties of the unc-64 gene encoding a Caenorhabditis elegans syntaxin. J. Biol. Chem. 273:2192-2198[Abstract/Free Full Text].

OGG, S. and G. RUVKUN, 1998  The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol. Cell 2:887-893[Medline].

OGG, S., S. PARADIS, S. GOTTLIEB, G. I. PATTERSON, and L. LEE et al., 1997  The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans.. Nature 389:994-999[Medline].

PADGETT, R. W., P. DAS, and S. KRISHNA, 1998  TGF-ß signaling, Smads, and tumor suppressors. Bioessays 20:382-390[Medline].

PARADIS, S., M. AILION, A. TOKER, J. H. THOMAS, and G. RUVKUN, 1999  A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans.. Genes Dev. 13:1438-1452[Abstract/Free Full Text].

PATTERSON, G. I. and R. W. PADGETT, 2000  TGF ß-related pathways. Roles in Caenorhabditis elegans development. Trends Genet. 16:27-33[Medline].

PATTERSON, G. I., A. KOWEEK, A. WONG, Y. LIU, and G. RUVKUN, 1997  The DAF-3 Smad protein antagonizes TGF-ß-related receptor signaling in the Caenorhabditis elegans dauer pathway. Genes Dev. 11:2679-2690[Abstract/Free Full Text].

PERKINS, L. A., E. M. HEDGECOCK, J. N. THOMSON, and J. G. CULOTTI, 1986  Mutant sensory cilia in the nematode Caenorhabditis elegans.. Dev. Biol. 117:456-487[Medline].

PRASAD, B. C., B. YE, R. ZACKHARY, K. SCHRADER, and G. SEYDOUX et al., 1998  unc-3, a gene required for axonal guidance in Caenorhabditis elegans, encodes a member of the O/E family of transcription factors. Development 125:1561-1568[Abstract].

REN, P., C. S. LIM, R. JOHNSEN, P. S. ALBERT, and D. PILGRIM et al., 1996  Control of C. elegans larval development by neuronal expression of a TGF-ß homolog. Science 274:1389-1391[Abstract/Free Full Text].

RIDDLE, D. L., and P. S. ALBERT, 1997 Genetic and environmental regulation of dauer larva development, pp. 739–768 in C. elegans II, edited by D. L. RIDDLE, T. BLUMENTHAL, B. J. MEYER and J. R. PRIESS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

RIDDLE, D. L., M. M. SWANSON, and P. S. ALBERT, 1981  Interacting genes in nematode dauer larva formation. Nature 290:668-671[Medline].

ROAYAIE, K., J. G. CRUMP, A. SAGASTI, and C. I. BARGMANN, 1998  The G protein ODR-3 mediates olfactory and nociceptive function and controls cilium morphogenesis in C. elegans olfactory neurons. Neuron 20:55-67[Medline].

ROUAULT, J. P., P. E. KUWABARA, O. M. SINILNIKOVA, L. DURET, and D. THIERRY-MIEG et al., 1999  Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN. Curr. Biol. 9:329-332[Medline].

SAIFEE, O., L. WEI, and M. L. NONET, 1998  The Caenorhabditis elegans unc-64 locus encodes a syntaxin that interacts genetically with synaptobrevin. Mol. Biol. Cell 9:1235-1252[Abstract/Free Full Text].

SAVAGE, C., P. DAS, A. L. FINELLI, S. R. TOWNSEND, and C. Y. SUN et al., 1996  Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components. Proc. Natl. Acad. Sci. USA 93:790-794[Abstract/Free Full Text].

SCHACKWITZ, W. S., T. INOUE, and J. H. THOMAS, 1996  Chemosensory neurons function in parallel to mediate a pheromone response in C. elegans. Neuron 17:719-728[Medline].

SCHINKMANN, K. and C. LI, 1992  Localization of FMRFamide-like peptides in Caenorhabditis elegans.. J. Comp. Neurol. 316:251-260[Medline].

SENGUPTA, P., H. A. COLBERT, and C. I. BARGMANN, 1994  The C. elegans gene odr-7 encodes an olfactory-specific member of the nuclear receptor superfamily. Cell 79:971-980[Medline].

SENGUPTA, P., J. H. CHOU, and C. I. BARGMANN, 1996  odr-10 encodes a seven transmembrane domain olfactory receptor required for responses to the odorant diacetyl. Cell 84:899-909[Medline].

STARICH, T. A., R. K. HERMAN, C. K. KARI, W.-H. YEH, and W. S. SCHACKWITZ et al., 1995  Mutations affecting the chemosensory neurons of Caenorhabditis elegans.. Genetics 139:171-188[Abstract].

SUZUKI, Y., M. D. YANDELL, P. J. ROY, S. KRISHNA, and C. SAVAGE-DUNN et al., 1999  A BMP homolog acts as a dose-dependent regulator of body size and male tail patterning in Caenorhabditis elegans.. Development 126:241-250[Abstract].

SZE, J. Y., M. VICTOR, C. LOER, Y. SHI, and G. RUVKUN, 2000  Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature 403:560-564[Medline].

THATCHER, J. D., C. HAUN, and P. G. OKKEMA, 1999  The DAF-3 Smad binds DNA and represses gene expression in the Caenorhabditis elegans pharynx. Development 126:97-107[Abstract].

THOMAS, J. H., 1990  Genetic analysis of defecation in Caenorhabditis elegans.. Genetics 124:855-872[Abstract].

THOMAS, J. H., 1993  Chemosensory regulation of development in C. elegans.. Bioessays 15:791-796[Medline].

THOMAS, J. H., D. A. BIRNBY, and J. J. VOWELS, 1993  Evidence for parallel processing of sensory information controlling dauer formation in Caenorhabditis elegans.. Genetics 134:1105-1117[Abstract].

TISSENBAUM, H. A., J. HAWDON, M. PERREGAUX, P. HOTEZ, and L. GUARENTE et al., 2000  A common muscarinic pathway for diapause recovery in the distantly related nematode species Caenorhabditis elegans and Ancylostoma caninum.. Proc. Natl. Acad. Sci. USA 97:460-465[Abstract/Free Full Text].

TRENT, C., N. TSUNG, and H. R. HORVITZ, 1983  Egg-laying defective mutants of the nematode Caenorhabditis elegans.. Genetics 104:619-647[Abstract/Free Full Text].

TROEMEL, E. R., 1999  Chemosensory signaling in C. elegans.. Bioessays 21:1011-1020[Medline].

TROEMEL, E. R., J. H. CHOU, N. D. DWYER, H. A. COLBERT, and C. I. BARGMANN, 1995  Divergent seven transmembrane receptors are candidate chemosensory receptors in C. elegans. Cell 83:207-218[Medline].

TROEMEL, E. R., B. E. KIMMEL, and C. I. BARGMANN, 1997  Reprogramming chemotaxis responses: sensory neurons define olfactory preferences in C. elegans. Cell 91:161-169[Medline].

TROEMEL, E. R., A. SAGASTI, and C. I. BARGMANN, 1999  Lateral signaling mediated by axon contact and calcium entry regulates asymmetric odorant receptor expression in C. elegans. Cell 99:387-398[Medline].

VOWELS, J. J. and J. H. THOMAS, 1992  Genetic analysis of chemosensory control of dauer formation in Caenorhabditis elegans.. Genetics 130:105-123[Abstract].

VOWELS, J. J. and J. H. THOMAS, 1994  Multiple chemosensory defects in daf-11 and daf-21 mutants of Caenorhabditis elegans.. Genetics 138:303-316[Abstract].

WAGGONER, L. E., G. T. ZHOU, R. W. SCHAFER, and W. R. SCHAFER, 1998  Control of alternative behavioral states by serotonin in Caenorhabditis elegans. Neuron 21:203-214[Medline].

WAGGONER, L. E., L. A. HARDAKER, S. GOLIK, and W. R. SCHAFER, 2000  Effect of a neuropeptide gene on behavioral states in Caenorhabditis elegans egg-laying. Genetics 154:1181-1192[Abstract/Free Full Text].

WARD, S., 1973  Chemotaxis by the nematode Caenorhabditis elegans: identification of attractants and analysis of the response by use of mutants. Proc. Natl. Acad. Sci. USA 70:817-821[Abstract/Free Full Text].

WEINSHENKER, D., G. GARRIGA, and J. H. THOMAS, 1995  Genetic and pharmacological analysis of neurotransmitters controlling egg laying in C. elegans.. J. Neurosci. 15:6975-6985[Abstract/Free Full Text].

WHITE, J. G., E. SOUTHGATE, J. N. THOMSON, and S. BRENNER, 1986  The structure of the nervous system of the nematode Caenorhabditis elegans.. Philos. Trans. R. Soc. Lond. Ser. B 314:1-340.

ZWAAL, R. R., J. E. MENDEL, P. W. STERNBERG, and R. H. PLASTERK, 1997  Two neuronal G proteins are involved in chemosensation of the Caenorhabditis elegans dauer-inducing pheromone. Genetics 145:715-727[Abstract].

This article has been cited by other articles:

				M. Moussaif and J. Y. Sze Intraflagellar Transport/Hedgehog-Related Signaling Components Couple Sensory Cilium Morphology and Serotonin Biosynthesis in Caenorhabditis elegans J. Neurosci., April 1, 2009; 29(13): 4065 - 4075. [Abstract] [Full Text] [PDF]

				R. Jovelin, J. P. Dunham, F. S. Sung, and P. C. Phillips High Nucleotide Divergence in Developmental Regulatory Genes Contrasts With the Structural Elements of Olfactory Pathways in Caenorhabditis Genetics, April 1, 2009; 181(4): 1387 - 1397. [Abstract] [Full Text] [PDF]

				B. J. Lesch, A. R. Gehrke, M. L. Bulyk, and C. I. Bargmann Transcriptional regulation and stabilization of left-right neuronal identity in C. elegans Genes & Dev., February 1, 2009; 23(3): 345 - 358. [Abstract] [Full Text] [PDF]

				A. M. van der Linden, S. Wiener, Y.-j. You, K. Kim, L. Avery, and P. Sengupta The EGL-4 PKG Acts With KIN-29 Salt-Inducible Kinase and Protein Kinase A to Regulate Chemoreceptor Gene Expression and Sensory Behaviors in Caenorhabditis elegans Genetics, November 1, 2008; 180(3): 1475 - 1491. [Abstract] [Full Text] [PDF]

				N. Fielenbach and A. Antebi C. elegans dauer formation and the molecular basis of plasticity Genes & Dev., August 15, 2008; 22(16): 2149 - 2165. [Abstract] [Full Text] [PDF]

				R. L. Hong, H. Witte, and R. J. Sommer Natural variation in Pristionchus pacificus insect pheromone attraction involves the protein kinase EGL-4 PNAS, June 3, 2008; 105(22): 7779 - 7784. [Abstract] [Full Text] [PDF]

				N. Watanabe, T. Ishihara, and Y. Ohshima Mutants carrying two sma mutations are super small in the nematode C. elegans Genes Cells, May 1, 2007; 12(5): 603 - 609. [Abstract] [Full Text] [PDF]

				D. M. Raizen, K. M. Cullison, A. I. Pack, and M. V. Sundaram A Novel Gain-of-Function Mutant of the Cyclic GMP-Dependent Protein Kinase egl-4 Affects Multiple Physiological Processes in Caenorhabditis elegans Genetics, May 1, 2006; 173(1): 177 - 187. [Abstract] [Full Text] [PDF]

				N. Watanabe, Y. Nagamatsu, K. Gengyo-Ando, S. Mitani, and Y. Ohshima Control of body size by SMA-5, a homolog of MAP kinase BMK1/ERK5, in C. elegans Development, July 15, 2005; 132(14): 3175 - 3184. [Abstract] [Full Text] [PDF]

				Y. Nakano, Y. Nagamatsu, and Y. Ohshima cGMP and a germ-line signal control body size in C. elegans through cGMP-dependent protein kinase EGL-4 Genes Cells, September 1, 2004; 9(9): 773 - 779. [Abstract] [Full Text] [PDF]

				E. E. Voronezhskaya, M. Yu. Khabarova, and L. P. Nezlin Apical sensory neurones mediate developmental retardation induced by conspecific environmental stimuli in freshwater pulmonate snails Development, August 1, 2004; 131(15): 3671 - 3680. [Abstract] [Full Text] [PDF]

				L. S. da Graca, K. K. Zimmerman, M. C. Mitchell, M. Kozhan-Gorodetska, K. Sekiewicz, Y. Morales, and G. I. Patterson,, DAF-5 is a Ski oncoprotein homolog that functions in a neuronal TGF{beta} pathway to regulate C. elegans dauer development Development, January 15, 2004; 131(2): 435 - 446. [Abstract] [Full Text] [PDF]

				M. Ailion and J. H. Thomas Isolation and Characterization of High-Temperature-Induced Dauer Formation Mutants in Caenorhabditis elegans Genetics, September 1, 2003; 165(1): 127 - 144. [Abstract] [Full Text] [PDF]

				B. C. Kraemer, B. Zhang, J. B. Leverenz, J. H. Thomas, J. Q. Trojanowski, and G. D. Schellenberg From the Cover: Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy PNAS, August 19, 2003; 100(17): 9980 - 9985. [Abstract] [Full Text] [PDF]

				Y. Yamada and Y. Ohshima Distribution and movement of Caenorhabditis elegans on a thermal gradient J. Exp. Biol., August 1, 2003; 206(15): 2581 - 2593. [Abstract] [Full Text] [PDF]

				K. Ohkura, N. Suzuki, T. Ishihara, and I. Katsura SDF-9, a protein tyrosine phosphatase-like molecule, regulates the L3/dauer developmental decision through hormonal signaling in C. elegans Development, July 15, 2003; 130(14): 3237 - 3248. [Abstract] [Full Text] [PDF]

				T. Hirose, Y. Nakano, Y. Nagamatsu, T. Misumi, H. Ohta, and Y. Ohshima Cyclic GMP-dependent protein kinase EGL-4 controls body size and lifespan in C. elegans Development, March 15, 2003; 130(6): 1089 - 1099. [Abstract] [Full Text] [PDF]

				R. B. R. Azevedo, P. D. Keightley, C. Lauren-Maatta, L. L. Vassilieva, M. Lynch, and A. M. Leroi Spontaneous Mutational Variation for Body Size in Caenorhabditis elegans Genetics, October 1, 2002; 162(2): 755 - 765. [Abstract] [Full Text] [PDF]

				M. Ailion and J. H. Thomas Dauer Formation Induced by High Temperatures in Caenorhabditis elegans Genetics, November 1, 2000; 156(3): 1047 - 1067. [Abstract] [Full Text]